Skip to content
DraconiticResearch
Search Sources API
203,948 studies31 sourcesUpdated 6 min ago
Peer-reviewedCC BY-NC-NDIScience

Targeting mutant NPM1-expressing AML with T cell receptor-like antibodies

5 more authors

Related

  1. Modelling the efficacy of CAR-CIK cell immunotherapy targeting MET-expressing mesothelioma cells
    Federica Padovano, Andrea Maria Lombardi, Silvia Novello +4
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textOncologyCrossref
  2. The thrombopoietin receptor S264F mutant drives MPN with marrow fibrosis through a dual mechanism
    Charlotte Lees, Emile Brandt, Emmanuel Dutranoix +7
    HemaSpherePeer-reviewedCC BY 4.0Full textHuman geneticsHAL
  3. Amivantamab and lazertinib in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer with brain and leptomeningeal metastases: an editorial on efficacy, challenges in assessment, and future directions.
    Vinay R Nittur, Yoojin Jo, Misako Nagasaka
    Translational lung cancer researchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  4. Targeting Integrins in Triple Negative Breast Cancer: Therapeutic Potential of Monoclonal Antibodies, PARP Inhibitors, Synthetic Peptides, and Aptamers
    Mobina Darabi, Zeynab Zahedi, Kosar Zolfaghari +4
    Cancer medicinePeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  5. Severe hypothyroidism with mixed thyrotropin receptor antibodies and diffuse thyroid uptake
    JCEM case reportsPeer-reviewedCC BY-NC-NDFull textEndocrinology & metabolismEurope PMC
BibTeX
@article{hong2026targeting,
  title = {{Targeting mutant NPM1-expressing AML with T cell receptor-like antibodies}},
  author = {Yunda Hong and Dabing Chen and Jingjing Xu and Yanxin Chen and Yang Shi and Zikang Wang and Congling Gan and Zihan Wang and Qian Li and Jiahua Gao and Huilin Guo and Ningshao Xia and Yangtao Wu and Tianying Zhang and Quan Yuan and Ting Yang and Jianda Hu},
  journal = {IScience},
  year = {2026},
  month = sep,
  doi = {10.1016/j.isci.2026.117630},
  url = {https://europepmc.org/article/PMC/PMC13657108},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Targeting mutant NPM1-expressing AML with T cell receptor-like antibodies
AU  - Yunda Hong
AU  - Dabing Chen
AU  - Jingjing Xu
AU  - Yanxin Chen
AU  - Yang Shi
AU  - Zikang Wang
AU  - Congling Gan
AU  - Zihan Wang
AU  - Qian Li
AU  - Jiahua Gao
AU  - Huilin Guo
AU  - Ningshao Xia
AU  - Yangtao Wu
AU  - Tianying Zhang
AU  - Quan Yuan
AU  - Ting Yang
AU  - Jianda Hu
PY  - 2026
DA  - 2026/09/30
JO  - IScience
DO  - 10.1016/j.isci.2026.117630
UR  - https://europepmc.org/article/PMC/PMC13657108
SN  - 2589-0042
ER  -